EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited 1846.HK Peers
See (1846.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 1846.HK | HK$2.73 | -2.50% | 857M | 10.92 | HK$0.25 | +2.37% |
| 6618.HK | HK$43.00 | -0.69% | 137.6B | 29.86 | HK$1.44 | N/A |
| 6078.HK | HK$15.26 | +0.66% | 9.3B | 14.67 | HK$1.04 | N/A |
| 1951.HK | HK$3.06 | -2.24% | 8.3B | 27.82 | HK$0.11 | N/A |
| 2273.HK | HK$34.35 | -0.72% | 8.1B | 25.83 | HK$1.33 | +1.57% |
| 2373.HK | HK$30.25 | +0.33% | 7.1B | 28.01 | HK$1.08 | +1.55% |
| 1515.HK | HK$4.10 | +0.74% | 5.3B | 8.37 | HK$0.49 | +3.52% |
| 2453.HK | HK$5.97 | +4.74% | 4.4B | -8.78 | -HK$0.68 | N/A |
| 3309.HK | HK$1.80 | -0.55% | 2.2B | -16.36 | -HK$0.11 | +1.11% |
| 2219.HK | HK$2.85 | +2.15% | 2B | 9.19 | HK$0.31 | +8.77% |
Stock Comparison
1846.HK vs 6618.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 6618.HK has a market cap of 137.6B. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 6618.HK trades at HK$43.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 6618.HK's P/E ratio is 29.86. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 6618.HK's ROE of +0.08%. Regarding short-term risk, 1846.HK is more volatile compared to 6618.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 6078.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 6078.HK has a market cap of 9.3B. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 6078.HK trades at HK$15.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 6078.HK's P/E ratio is 14.67. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 6078.HK's ROE of +0.09%. Regarding short-term risk, 1846.HK is more volatile compared to 6078.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 1951.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 1951.HK has a market cap of 8.3B. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 1951.HK trades at HK$3.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 1951.HK's P/E ratio is 27.82. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 1951.HK's ROE of +0.03%. Regarding short-term risk, 1846.HK is more volatile compared to 1951.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 2273.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 2273.HK has a market cap of 8.1B. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 2273.HK trades at HK$34.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 2273.HK's P/E ratio is 25.83. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 2273.HK's ROE of +0.13%. Regarding short-term risk, 1846.HK is more volatile compared to 2273.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 2373.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 2373.HK has a market cap of 7.1B. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 2373.HK trades at HK$30.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 2373.HK's P/E ratio is 28.01. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 2373.HK's ROE of +0.26%. Regarding short-term risk, 1846.HK is more volatile compared to 2373.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 1515.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 1515.HK has a market cap of 5.3B. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 1515.HK trades at HK$4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 1515.HK's P/E ratio is 8.37. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 1515.HK's ROE of +0.09%. Regarding short-term risk, 1846.HK is more volatile compared to 1515.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 2453.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 2453.HK has a market cap of 4.4B. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 2453.HK trades at HK$5.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 2453.HK's P/E ratio is -8.78. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 2453.HK's ROE of -0.25%. Regarding short-term risk, 1846.HK is less volatile compared to 2453.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 3309.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 3309.HK has a market cap of 2.2B. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 3309.HK trades at HK$1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 3309.HK's P/E ratio is -16.36. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 3309.HK's ROE of -0.08%. Regarding short-term risk, 1846.HK is more volatile compared to 3309.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 2219.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 2219.HK has a market cap of 2B. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 2219.HK trades at HK$2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 2219.HK's P/E ratio is 9.19. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 2219.HK's ROE of +0.08%. Regarding short-term risk, 1846.HK is more volatile compared to 2219.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 0708.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 0708.HK has a market cap of 1.8B. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 0708.HK trades at HK$0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 0708.HK's P/E ratio is -0.07. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 0708.HK's ROE of +0.67%. Regarding short-term risk, 1846.HK is less volatile compared to 0708.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 1526.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 1526.HK has a market cap of 1.8B. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 1526.HK trades at HK$1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 1526.HK's P/E ratio is 5.43. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 1526.HK's ROE of +0.23%. Regarding short-term risk, 1846.HK is less volatile compared to 1526.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 3886.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 3886.HK has a market cap of 1.6B. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 3886.HK trades at HK$0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 3886.HK's P/E ratio is -7.93. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 3886.HK's ROE of -0.07%. Regarding short-term risk, 1846.HK is more volatile compared to 3886.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 9960.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 9960.HK has a market cap of 1.4B. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 9960.HK trades at HK$1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 9960.HK's P/E ratio is -22.67. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 9960.HK's ROE of -0.02%. Regarding short-term risk, 1846.HK is more volatile compared to 9960.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 6639.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 6639.HK has a market cap of 1.2B. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 6639.HK trades at HK$2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 6639.HK's P/E ratio is 41.00. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 6639.HK's ROE of +0.01%. Regarding short-term risk, 1846.HK is more volatile compared to 6639.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 9906.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 9906.HK has a market cap of 900M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 9906.HK trades at HK$1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 9906.HK's P/E ratio is 21.43. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 9906.HK's ROE of +0.05%. Regarding short-term risk, 1846.HK is more volatile compared to 9906.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 0383.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 0383.HK has a market cap of 876.3M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 0383.HK trades at HK$0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 0383.HK's P/E ratio is 27.00. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 0383.HK's ROE of +0.02%. Regarding short-term risk, 1846.HK is more volatile compared to 0383.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 1989.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 1989.HK has a market cap of 812.6M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 1989.HK trades at HK$0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 1989.HK's P/E ratio is -22.50. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 1989.HK's ROE of -0.16%. Regarding short-term risk, 1846.HK is more volatile compared to 1989.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 3869.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 3869.HK has a market cap of 704.3M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 3869.HK trades at HK$5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 3869.HK's P/E ratio is -16.77. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 3869.HK's ROE of -0.11%. Regarding short-term risk, 1846.HK is less volatile compared to 3869.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 2120.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 2120.HK has a market cap of 703.3M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 2120.HK trades at HK$9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 2120.HK's P/E ratio is 10.21. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 2120.HK's ROE of +0.05%. Regarding short-term risk, 1846.HK is less volatile compared to 2120.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 3689.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 3689.HK has a market cap of 577.8M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 3689.HK trades at HK$1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 3689.HK's P/E ratio is 36.00. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 3689.HK's ROE of +0.04%. Regarding short-term risk, 1846.HK is more volatile compared to 3689.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 2389.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 2389.HK has a market cap of 533.2M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 2389.HK trades at HK$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 2389.HK's P/E ratio is -4.40. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 2389.HK's ROE of -0.07%. Regarding short-term risk, 1846.HK is more volatile compared to 2389.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 2189.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 2189.HK has a market cap of 450M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 2189.HK trades at HK$0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 2189.HK's P/E ratio is 6.43. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 2189.HK's ROE of +0.16%. Regarding short-term risk, 1846.HK is more volatile compared to 2189.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 1518.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 1518.HK has a market cap of 390.4M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 1518.HK trades at HK$0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 1518.HK's P/E ratio is 7.27. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 1518.HK's ROE of +0.09%. Regarding short-term risk, 1846.HK is more volatile compared to 1518.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 0722.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 0722.HK has a market cap of 383.8M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 0722.HK trades at HK$0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 0722.HK's P/E ratio is 9.60. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 0722.HK's ROE of +0.06%. Regarding short-term risk, 1846.HK is more volatile compared to 0722.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 1419.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 1419.HK has a market cap of 315M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 1419.HK trades at HK$0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 1419.HK's P/E ratio is 13.83. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 1419.HK's ROE of +0.03%. Regarding short-term risk, 1846.HK is more volatile compared to 1419.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 8405.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 8405.HK has a market cap of 276M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 8405.HK trades at HK$0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 8405.HK's P/E ratio is 9.86. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 8405.HK's ROE of +0.14%. Regarding short-term risk, 1846.HK is more volatile compared to 8405.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 0286.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 0286.HK has a market cap of 251.6M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 0286.HK trades at HK$1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 0286.HK's P/E ratio is -0.86. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 0286.HK's ROE of -0.26%. Regarding short-term risk, 1846.HK is more volatile compared to 0286.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 2293.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 2293.HK has a market cap of 201.2M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 2293.HK trades at HK$0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 2293.HK's P/E ratio is 8.33. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 2293.HK's ROE of +0.11%. Regarding short-term risk, 1846.HK is more volatile compared to 2293.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 8143.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 8143.HK has a market cap of 156.6M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 8143.HK trades at HK$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 8143.HK's P/E ratio is -4.43. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 8143.HK's ROE of -0.29%. Regarding short-term risk, 1846.HK is less volatile compared to 8143.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 8357.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 8357.HK has a market cap of 104.8M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 8357.HK trades at HK$0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 8357.HK's P/E ratio is -16.80. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 8357.HK's ROE of -0.01%. Regarding short-term risk, 1846.HK is less volatile compared to 8357.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 2135.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 2135.HK has a market cap of 70.2M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 2135.HK trades at HK$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 2135.HK's P/E ratio is -1.05. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 2135.HK's ROE of -0.21%. Regarding short-term risk, 1846.HK is more volatile compared to 2135.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 8307.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 8307.HK has a market cap of 53.2M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 8307.HK trades at HK$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 8307.HK's P/E ratio is -13.40. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 8307.HK's ROE of -0.30%. Regarding short-term risk, 1846.HK is more volatile compared to 8307.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 8161.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 8161.HK has a market cap of 13.9M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 8161.HK trades at HK$0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 8161.HK's P/E ratio is -2.09. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 8161.HK's ROE of -2.14%. Regarding short-term risk, 1846.HK is more volatile compared to 8161.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.
1846.HK vs 8437.HK Comparison
1846.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1846.HK stands at 857M. In comparison, 8437.HK has a market cap of 10.7M. Regarding current trading prices, 1846.HK is priced at HK$2.73, while 8437.HK trades at HK$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1846.HK currently has a P/E ratio of 10.92, whereas 8437.HK's P/E ratio is -0.50. In terms of profitability, 1846.HK's ROE is +0.07%, compared to 8437.HK's ROE of +0.12%. Regarding short-term risk, 1846.HK is more volatile compared to 8437.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1846.HK.